We found that compared with the ApoE–/– mice treated with H. pylori-derived-OMVs, there were less atherosclerosis plaque formation in ApoE–/– mice treated with LPS-depleted OMVs or OMVs originated from CagA-negative bacterial strain (Figure 4G). The gene discussed is S100A8; the disease is atherosclerosis.